Persistent Asset Partners Ltd

Position in RVMD — Revolution Medicines, Inc.

CIK 2056052 HONG KONG, K3

Back to RVMD Full portfolio

Position in RVMD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$7,252,604

+$4,719,923 QoQ

Shares Held

38,726

+48.7% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

2.41%

of 13F equity value

Holder Rank

#216

of 687 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$30,827

PutShares

317

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. RVMD ranks #1 (9.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc. This page	38,726	$7,252,604
2	ABVX	Abivax S.A.	44,256	$5,897,553
3	COGT	Cogent Biosciences, Inc.	138,272	$5,351,125
4	BMRN	Biomarin Pharmaceutical Inc	79,933	$4,573,766
5	VKTX	Viking Therapeutics, Inc.	112,736	$4,397,831
6	EWTX	Edgewise Therapeutics, Inc.	69,441	$2,821,387
7	KOD	Kodiak Sciences Inc.	56,052	$2,183,785
8	IMCR	Immunocore Holdings plc	65,214	$2,070,544

All Filings in RVMD

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,252,604	38,726	+48.7%	Shares	Sole	2026-08-07
2026-03-31	$30,827	317	—	Put	Sole	2026-05-12
2026-03-31	$2,532,681	26,043	+48.5%	Shares	Sole	2026-05-12
2025-12-31	$1,396,821	17,537	+28.7%	Shares	Sole	2026-02-17
2025-09-30	$636,380	13,627	-25.3%	Shares	Sole	2026-01-15
2025-06-30	$671,012	18,239	—	Shares	Sole	2025-08-11
No filing history on record for this holder in this stock.